[HTML][HTML] Updated results from an ongoing phase 1 clinical study of bb21217 anti-Bcma CAR T cell therapy
JG Berdeja, M Alsina, ND Shah, DS Siegel… - Blood, 2019 - Elsevier
Introduction: Chimeric antigen receptor (CAR) T cell therapy directed against B cell
maturation antigen (BCMA) has shown promising results for the treatment of relapsed …
maturation antigen (BCMA) has shown promising results for the treatment of relapsed …
Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy
JG Berdeja, M Alsina, ND Shah, DS Siegel… - 2019 - ashpublications.org
Introduction: Chimeric antigen receptor (CAR) T cell therapy directed against B cell
maturation antigen (BCMA) has shown promising results for the treatment of relapsed …
maturation antigen (BCMA) has shown promising results for the treatment of relapsed …